See All of This Company's Exhibits Find More Exhibits Like This
• |
Total revenues for the first half of 2024 were $6.1 million,
an increase of 7% compared to $5.7 million in the first half of 2023. The majority of revenues were product sales, driven by commencement of shipment of engineering sample of space-grade ASICs. The decrease in revenues from development
services and preproduction provided to customers was primarily due to the completion of various development services agreements and the shift towards product sales.
|
• |
Gross profit for the first half of 2024 was $4.5 million (gross margin of 74%), a 96% increase from $2.3 million (gross margin of 41%) in the first half of 2023. The increase in
gross profit and margin was due to the product mix favoring higher-margin space-grade ASIC products.
|
• |
Operating loss was $13.7 million in the first half of 2024, a
17% improvement from the loss of $16.6 million in the first half of 2023. The increase was mainly attributed to a higher gross profit and a reduction in operating expenses, as described below.
|
• |
Expenses Breakdown:
|
• |
Research and Development (R&D): $13.3 million, a 1%
decrease compared to $13.4 million for the first half of 2023. R&D expenses were primarily driven by the Company’s significant efforts to develop its space grade ASICs and bring them to maturity.
|
• |
Selling and Marketing: $1.1 million, a 21% decrease compared
to $1.4 million for the first half of 2023. The decrease was primarily due to a decrease in payroll and related costs.
|
• |
General and Administrative: $3.9 million, a 7% decrease
compared to $4.2 million for the first half of 2023. The decrease was mainly due to a decrease in legal fees and insurance costs.
|
• |
Finance expenses: $7.6 million, a 43% increase compared to
$5.3 million for the first half of 2023. The increase was mainly attributed to $1.5 million of interest accruals recorded on advanced payments from MDA Space and Robotics Limited.
|
• |
Net loss for the first half of 2024 was $21.3 million, or
$0.25 per basic and diluted share, a 54% improvement compared with a net loss of $46.3 million, or $0.57 per basic and diluted share, in the first half of 2023. The net loss in the first half of 2023 was impacted by a $24.1 million
derivatives revaluation, whereas no such revaluation occurred in the first half of 2024.
|
• |
Cash and Cash Equivalents: Cash and cash equivalents as of
June 30, 2024, amounted to $7.9 million, compared to $14.0 million as of December 31, 2023.
|
For the six-month period
ended June 30
|
||||||||
2024
|
2023
|
|||||||
USD in thousands, except share and per share data
|
||||||||
Revenues:
|
||||||||
Development services and preproduction
|
1,641
|
4,129
|
||||||
Sale of products
|
4,410
|
1,540
|
||||||
Total revenues
|
6,051
|
5,669
|
||||||
Cost of sales and services:
|
||||||||
Development services and preproduction
|
291
|
2,673
|
||||||
Sale of products
|
1,267
|
649
|
||||||
Total cost of sales and services
|
1,558
|
3,322
|
||||||
Gross profit
|
4,493
|
2,347
|
||||||
Research and development expenses, net
|
13,275
|
13,390
|
||||||
Selling and marketing expenses
|
1,059
|
1,395
|
||||||
General and administrative expenses
|
3,873
|
4,194
|
||||||
Loss from operations
|
(13,714
|
)
|
(16,632
|
)
|
||||
Finance Income
|
87
|
37
|
||||||
Finance Expenses
|
(7,615
|
)
|
(5,296
|
)
|
||||
Derivatives Revaluation
|
-
|
(24,104
|
)
|
|||||
Company’s share in the loss of a company accounted by equity method, net
|
(19
|
)
|
(261
|
)
|
||||
Loss before income taxes
|
(21,261
|
)
|
(46,256
|
)
|
||||
Income taxes
|
-
|
-
|
||||||
Loss for the period
|
(21,261
|
)
|
(46,256
|
)
|
||||
Other comprehensive income (loss) net of tax:
|
||||||||
Exchange gain (loss) arising on translation of foreign operations
|
-
|
(272
|
)
|
|||||
Total comprehensive loss for the period
|
(21,261
|
)
|
(46,528
|
)
|
||||
Basic and diluted loss per share (in dollars)
|
(0.25
|
)
|
(0.57
|
)
|
||||
Basic and diluted weighted average common shares outstanding
|
83,777,164
|
80,732,123
|
June 30,
|
December 31,
|
|||||||
2024
|
2023
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
7,922
|
13,979
|
||||||
Trade accounts receivable, net
|
2,455
|
2,260
|
||||||
Contract assets
|
3,358
|
4,091
|
||||||
Prepaid expenses and other
|
1,735
|
2,332
|
||||||
Government departments and agencies receivables
|
4,130
|
3,076
|
||||||
Related parties
|
46
|
75
|
||||||
Promissory notes
|
2,841
|
20,000
|
||||||
Inventory
|
1,903
|
1,475
|
||||||
Total current assets
|
24,390
|
47,288
|
||||||
NON-CURRENT ASSETS:
|
||||||||
Other long-term receivables
|
2,000
|
2,000
|
||||||
Right-of-use assets, net
|
1,895
|
2,235
|
||||||
Property, plant and equipment, net
|
1,934
|
1,420
|
||||||
Investment in Jet Talk
|
1,532
|
1,551
|
||||||
Long-term deposits
|
181
|
208
|
||||||
Total non-current assets
|
7,542
|
7,414
|
||||||
TOTAL ASSETS
|
31,932
|
54,702
|
June 30,
|
December 31,
|
|||||||
2024
|
2023
|
|||||||
LIABILITIES AND SHAREHOLDERS’ DEFICIT
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
1,388
|
1,378
|
||||||
Contract liabilities
|
120
|
1,720
|
||||||
Current interest payable of Long term loans from financial institutions, net
|
9,174
|
-
|
||||||
European Space Agency (“ESA”) advance payments
|
3,047
|
3,842
|
||||||
Prepayments from customers
|
2,758
|
3,858
|
||||||
Advanced payments from MDA Space and Robotics Limited, an affiliate of MDA Ltd. (“MDA”), against future orders
|
29,634
|
28,138
|
||||||
Lease liabilities
|
696
|
639
|
||||||
Other accounts payable and accrued expenses
|
4,724
|
9,704
|
||||||
Related parties
|
164
|
740
|
||||||
Total current liabilities
|
51,705
|
50,019
|
||||||
NON-CURRENT LIABILITIES:
|
||||||||
Long-term loans from financial institutions
|
56,581
|
59,792
|
||||||
Lease liabilities
|
1,653
|
2,067
|
||||||
Derivatives instruments liabilities
|
114
|
114
|
||||||
Liability for royalties payable
|
1,193
|
1,496
|
||||||
Total non-current liabilities
|
59,541
|
63,469
|
||||||
SHAREHOLDERS’ DEFICIT:
|
||||||||
Share capital
|
-
|
-
|
||||||
Share premium
|
451,826
|
451, 093
|
||||||
Capital reserves
|
1,444
|
1,444
|
||||||
Accumulated deficit
|
(532,584
|
)
|
(511,323
|
)
|
||||
Total shareholders’ deficit
|
(79,314
|
)
|
(58,786
|
)
|
||||
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT
|
31,932
|
54,702
|